NCT02792764View on ClinicalTrials.gov

Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
PORTs/Peripheral IVs Complication Rates
Trial Locations (2)

62301

Quincy Medical Group, Quincy

71103

Willis Knighton Cancer Center, Shreveport

Sponsors

Lead Sponsor

C. R. Bard
All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02792764 - Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs | Biotech Hunter | Biotech Hunter